Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Infant, Premature, Diseases

1,2-dipalmitoylphosphatidylcholine has been researched along with Infant, Premature, Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bancalari, A; Bancalari, E; d'Agostino, R; Gadzinowski, J; Kopelman, B; Kornacka, MK; Massaro, J; Merritt, TA; Moya, FR; Salinas, V; Schaber, CJ; Segal, R; Tsai, H1
Moen, MD; Perry, CM; Wellington, K1
Badon, T; Carnielli, VP; Cavicchioli, P; Cogo, PE; Giordano, G; Sauer, PJ; Torresin, M; Zacchello, F; Zimmermann, LJ1

Reviews

1 review(s) available for 1,2-dipalmitoylphosphatidylcholine and Infant, Premature, Diseases

ArticleYear
Lucinactant: in neonatal respiratory distress syndrome.
    Treatments in respiratory medicine, 2005, Volume: 4, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intercellular Signaling Peptides and Proteins; Peptides; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension; Treatment Outcome

2005

Trials

2 trial(s) available for 1,2-dipalmitoylphosphatidylcholine and Infant, Premature, Diseases

ArticleYear
A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Pediatrics, 2005, Volume: 115, Issue:4

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Female; Humans; Incidence; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Phosphatidylglycerols; Proteins; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Survival Analysis

2005
Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group.
    British medical journal (Clinical research ed.), 1987, Apr-18, Volume: 294, Issue:6578

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Cerebral Hemorrhage; Clinical Trials as Topic; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphatidylglycerols; Prospective Studies; Random Allocation; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

1987

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Infant, Premature, Diseases

ArticleYear
Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes.
    American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Carbon Isotopes; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Infant, Newborn; Infant, Premature, Diseases; Phospholipids; Pulmonary Surfactants; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Trachea

2000